Work

Abstract 2042: ROS1 single nucleotide variants predict favorable survival outcomes on immunotherapy regimens in non-small cell lung cancer

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-2042

Authors: Yue Wu, Jaclyn LoPiccolo, Sebastian Carrasco Pro, Krishna C. Bulusu, Etai Jacob, Alexander Gusev, Gerald J. Sun

Institutions: AstraZeneca (United States), Dana-Farber Cancer Institute

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409627529

Cites:

Cited by:

Related to: 10